Thorium dioxide: still around.

Area of Science:

• Radiology
• Oncology
• Nuclear Medicine

Background:

• Thorium dioxide (Thorotrast) was historically used as a contrast agent.
• Patients exposed to Thorotrast face an elevated risk of hepatic and other malignancies.
• Identifying these patients is critical for long-term health monitoring and management.

Observation:

• Presents three cases of patients with a history of Thorotrast administration.
• Details the characteristic radiologic findings associated with Thorotrast deposition on plain films.
• Illustrates the diagnostic appearance for physicians unfamiliar with this radiological sign.

Findings:

• Thorotrast exhibits a distinct, identifiable pattern on plain film radiography.
• Radiologic identification allows for the detection of individuals exposed to this radioactive agent.
• The findings emphasize the persistent radiological signature of Thorotrast.

Implications:

• Enhances the ability of physicians to recognize past Thorotrast exposure through imaging.
• Facilitates the identification and follow-up of patients at risk for Thorotrast-induced cancers.
• Improves patient management strategies for individuals with a history of Thorotrast exposure.